Cases & Deals

  • Home
  • Practices
  • Sunesis Pharmaceuticals successfully prosecutes U.S. patent for vosaroxin

Share

Sunesis Pharmaceuticals successfully prosecutes U.S. patent for vosaroxin

August 2011

Client(s) Sunesis Pharmaceuticals, Inc.

On behalf of Sunesis Pharmaceuticals, Inc., Jones Day successfully prosecuted a U.S. patent application for vosaroxin which is used in the treatment of leukemia. The patent issued as United States Patent No. 7,989,468.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.